Skip to content

The effect of synbiotics on airway

Non-control clinical trial of the effect on airway endocrine products by synbiotic administration

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs051200039
Enrollment
60
Registered
2020-07-30
Start date
2021-02-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After tracheotomy, after laryngotracheal separation After tracheotomy, after laryngotracheal separation

Interventions

Synprotec 1.0 g of food containing lactic acid bacteria and bifidobacterial live bacteria Oligosaccharide food 1 package 6.8g After meals, one package once for 1 to 3 times daily for 8 weeks.
synbiotic

Sponsors

Bitoh Yuko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Selection criteria Observation only A person who has a tracheotomy or laryngotracheal separation Persons over 3 years old upon obtaining consent A person who has obtained the written consent of the person or his or her proxy for their participation in this clinical study. Person with good general condition (Fever of 38 degrees or more does not last for more than 48 hours, WBC<12000 or CRP<2.0, etc. will be judged by the attending physician) Airway disease ; Including cerebral palsy ,upper airway obstruction ,laryngeal stenosis, tracheal stenosis, and tracheomalacia ,etc. Selection criterion Intervention with study drug Those who can orally administer the test drug in Selection Criteria Observation only

Exclusion criteria

Exclusion criteria: 1. Those who have undergone tracheotomy or laryngeal trachea within 6 months prior to obtaining consent 2. Those who received antibiotics within one month before obtaining consent 3. Persons with severe liver and renal dysfunction 4. Anyone who is allergic to drugs such as allergies or dairy products 5. Pregnant women and patients who may be pregnant or breastfeeding 6. Other persons who are judged inappropriate by the person in charge of this clinical study

Design outcomes

Primary

MeasureTime frame
Exam 1 Bacterial flora in the lower respiratory tract before administration of synbiotics Exam 2 Change in Bifidobacterium bacteria amount after 8 weeks, based on baseline before administration of synbiotics

Secondary

MeasureTime frame
Changes in other flora in the lower respiratory tract Oral bacterial flora / faecal flora / blood flora Prevention of pneumonia Defecation status Lower respiratory tract / oral / intestinal environment

Contacts

Public ContactYuichiro Tomioka

Kobe University Hospital

tomyking9821@gmail.com+81-78-382-5942

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026